Researchers Identify a Potential New HIV Vaccine/Therapy Target

News   Jun 04, 2012

 
Researchers Identify a Potential New HIV Vaccine/Therapy Target
 
 
 

RELATED ARTICLES

Quotient Clinical Signs Cocrystal Agreement with Nuformix

News

Partnership to evaluate cocrystal formulations using translational pharmaceutics.

READ MORE

Gilead Company Wins FDA Approval for CAR T Cancer Therapy for Treatment of Adult Lymphoma

News

Kite’s Yescarta™ (axicabtagene ciloleucel) becomes first CAR T therapy approved by the FDA for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.

READ MORE


 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE